Lumen Therapeutics is a private company headquartered in Mountain View, CA, that operates as a biopharmaceutical company. It was founded by Peter Alan Altman.

OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert in 1950 and headquartered in Irvine, CA.

Specializes in development of effective soft option products for pest control, particularly those based on insect behavior modifying chemicals

Cellegy Pharmaceuticals specialty biopharmaceutical company, that is primarily engaged in the development and commercialization of prescription drugs targeting women’s health care, including reduction in transmission of HIV and female sexual dysfunction, and gastrointestinal conditions using proprietary topical formulations and nitric oxide, or NO, donor technologies

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia, due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Revlimid is sold through proprietary risk-management distribution programs, to ensure safe and appropriate use of these pharmaceuticals. Vidaza is approved for the treatment of patients with MDS.

VuVatech offers dilators, including magnetic, clearance, non-magnetic, rectal, ohnuts, lubricants, therawands-pelvic wands, and neueve creams and vaginal suppositories.

AkPharma, Inc. is an American private company. The firm manufactures and markets dietary supplements.

XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regnite® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astellas Pharma Inc. XenoPort holds all other world-wide rights to gabapentin enacarbil. XenoPort's pipeline of product candidates includes potential treatments for patients with Parkinson's disease, relapsing-remitting multiple sclerosis and psoriasis.

TARIS Biomedical develops new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and retrieved using minimally-invasive, in-office procedures, enabling drug release to be tailored to match the needs of each disease.

Glenmark Pharmaceuticals SA, part of Glenmark Pharmaceuticals Ltd., is a Swiss company located in Neuch��tel. The firm develops and Manufactures pharmaceuticals.

Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

Dipharma is a European manufacturer of Active Pharmaceutical Ingredients that has been developing innovative and proprietary processes since 1949. We support our customers worldwide with a strong and well resourced R&D team, three cGMP facilities in Europe, and offer world-renowned expertise in handling hazardous chemical processes. Our customers can benefit from our broad portfolio of generic Active Pharmaceutical Ingredients and a wide range of advanced technologies available for custom synthesis. They can rely on the highest quality standards, but it does not stop there, they can count on our experience in innovation.

Edusa Pharmaceuticals, Inc. develops biotechnology products for the treatment of gastrointestinal disorders. The company was founded in October 2009 and is headquartered in Princeton, NJ.

Dynogen is a privately held, neuroscience-based pharmaceutical company focused on genitourinary (GU) and gastrointestinal (GI) disorders. The company is utilizing its knowledge of the nexus between neurology and GU/GI disorders, as well as its predictive in vitro and in vivo pharmacology platforms to rapidly build a pipeline of development programs. Today, Dynogen has two ongoing development programs, one for overactive bladder (OAB) and another for irritable bowel syndrome (IBS). The company will advance its OAB program into Phase IIa trials and enter the clinic with its IBS program later this year.

Kyowa Kirin Ltd., a subsidiary of Kirin Holdings Co., Ltd., is a British company located in London. The firm develops, manufactures and distributes pharmaceutical products. It was founded in 1998.\nThe company says this about itself: The principal activity of the Company is the distribution and sale of pharmaceutical products.

Dr. Willmar Schwabe GmbH & Co. KG engages in research, development, production, and distribution of generic drugs derived from plants. It offers herbal medicinal products, which include medicines for the treatment of memory loss, lack of concentration, anxiety, bronchitis, muscle and joint pain, enlarged prostate, neurodermatitis, eczemas, and sleeping problems. The company was founded by Willmar Schwabe in 1866 and is headquartered in Karlsruhe, Germany.

Shenzhen Funuo Biotechnology Co., Ltd., established on 2007-06-22, Business scope includes general business items:medicine,Biological product,Health Supplies,hygiene products,Technical development of diagnostic supplies(None of the above does not include medical,Diagnosis and treatment items and restricted items).,The licensing program is: